Mounjaro Blood Test UK: What to Monitor on Tirzepatide

1. What is Mounjaro, and why does monitoring differ?

Most weight-loss injections act on a single gut-hormone pathway. Tirzepatide acts on two: it is a dual GIP and GLP-1 receptor agonist. In practice that tends to mean stronger appetite suppression and larger average weight loss than semaglutide, the molecule behind Ozempic and Wegovy. You can read how those compare in our semaglutide blood test guide.

The monitoring logic is similar across the GLP-1 class, but the larger and faster the weight change, the more the supporting systems are worth watching. With tirzepatide, the two areas that deserve a little extra attention are nutrition and muscle preservation, simply because people often eat considerably less.

The NICE technology appraisal on tirzepatide for managing overweight and obesity sets out where it is recommended on the NHS. Whether your prescription is NHS or private, the principle is the same: a baseline, then periodic rechecks.

2. Blood markers worth a baseline before you start

A baseline taken before your first injection is the single most useful test you will do. Without it, you cannot tell whether a later change reflects the medication, the weight loss, or something that was already developing. A sensible baseline covers:

• Thyroid (TSH, ideally with Free T4 and Free T3)
• Liver function (ALT, ALP, albumin)
• Kidney function (urea, creatinine, eGFR)
• HbA1c and, where available, fasting glucose
• Full lipid profile (total, LDL, HDL, triglycerides, non-HDL)
• Ferritin and iron, vitamin D, B12 and folate
• Full blood count

Our Thyroid & Vital Organs panel covers thyroid (TSH, Free T4, Free T3), liver, kidney and a full cholesterol profile from a home finger-prick sample. HbA1c, ferritin and the vitamins sit in other panels or can be arranged through your GP, so build the combination that fits your situation rather than assuming one panel covers everything.

3. Thyroid: a safety check, not an afterthought

Tirzepatide carries a boxed warning relating to thyroid C-cell tumours seen in rodent studies. The relevance to humans is uncertain, but it is why the medicine is not used in people with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia type 2. Separately, meaningful weight loss can shift thyroid function as your metabolic rate adjusts.

A TSH test is the standard first-line screen, usually reported against a range of about 0.4 to 4.0 mIU/L. A reading drifting upward over time may suggest the thyroid is slowing; a low reading with symptoms such as tremor or a racing heart is worth raising with a clinician. New neck swelling, a persistent hoarse voice or difficulty swallowing should always be reviewed promptly rather than tracked at home.

For a fuller picture you can add Free T4 and Free T3, which show what the thyroid is actually producing rather than only what the brain is asking it to do.

4. Liver: the organ doing the heavy lifting

When you lose weight quickly, stored fat is mobilised and processed through the liver. This can nudge liver enzymes upward for a while. In most people the picture actually improves over months, because GLP-1 and dual-agonist drugs tend to reduce fat in the liver. The NHS estimates that up to one in three UK adults has early non-alcoholic fatty liver disease, so a baseline is genuinely useful.

ALT is the main marker of liver-cell stress. A mild early rise during rapid weight loss is common and often settles. A sustained climb, or a level well above the laboratory upper limit, is a flag to discuss with your prescriber rather than something to interpret alone. Our liver function test guide explains the full panel.

5. Kidney function and dehydration risk

Nausea and reduced fluid intake are common while the dose is being increased, and dehydration is the main reason kidney function can dip on these medicines. Checking creatinine and eGFR tells you how efficiently your kidneys are filtering.

An eGFR above 90 is generally considered normal, 60 to 89 suggests mild reduction worth keeping an eye on, and below 60 is a level to review with a clinician. A sudden fall of more than about a quarter from your baseline is a reason to seek advice, especially during a period of poor appetite or vomiting. Our kidney function guide walks through each marker.

6. HbA1c and lipids: the real progress markers

The number on the scale is the least interesting result of tirzepatide treatment. The metabolic improvements are what reduce long-term risk. HbA1c reflects your average blood sugar over the previous two to three months. Below 42 mmol/mol is in the normal range, 42 to 47 sits in the prediabetes band, and 48 or above is the diabetes range. Tirzepatide was first developed for type 2 diabetes, so improvement here is often clear.

Weight loss usually improves the lipid profile too: lower LDL and triglycerides, often higher HDL. If your weight is falling but lipids are not, it can point to a genetic driver worth discussing. Our cholesterol guide and HbA1c guide cover the ranges in detail.

7. Nutrients: the hidden cost of eating much less

This is the part most weight-loss services skip. Tirzepatide suppresses appetite strongly, so many people eat well below their usual intake. Fewer calories also means fewer vitamins and minerals, and over months that can show up as fatigue, hair thinning, brain fog and poor recovery. The markers worth keeping an eye on are ferritin, vitamin D, vitamin B12 and folate.

Ferritin below about 30 micrograms per litre is linked to fatigue even when haemoglobin looks normal. Vitamin D below 25 nmol/L is in the deficient range in UK terms. If you are also taking metformin alongside tirzepatide, B12 is worth watching a little more closely, since metformin is known to lower it over time. Any supplementation is best agreed with a clinician rather than guessed.

8. Muscle mass: tirzepatide's quiet trade-off

A meaningful share of the weight lost on these drugs can be lean mass rather than fat. A 2024 analysis in The Lancet Diabetes & Endocrinology reported that a sizeable proportion of weight lost on semaglutide was lean mass, and the same trade-off applies across the class. Muscle is your metabolic engine and your long-term independence, so it is worth protecting.

Blood tests cannot measure muscle directly, but testosterone trends can act as a loose proxy alongside how you feel and how your strength holds up. The practical defence is resistance training a few times a week and keeping protein intake adequate. Use the trend in your data, not a single reading, to judge whether your approach is working.

9. A sensible testing schedule

Most people test again once they reach their maintenance dose, since testing during the titration weeks gives a less stable picture. Your prescriber may suggest a different rhythm based on your history.

10. NHS Mounjaro and what monitoring you can expect

Mounjaro is being rolled out on the NHS for weight management in stages, with eligibility set out in the relevant NICE guidance. If you are prescribed through the NHS, your clinician should arrange the monitoring they judge necessary. If you have a private prescription through a weight-loss service, monitoring is often lighter, and many people choose to arrange their own broader testing.

Either way, bring your results back to the person who prescribes your medication. Blood markers are most useful as a conversation starter with a qualified clinician, not as a substitute for one.

11. Frequently asked questions